text
"['\n1. 요약재무정보\n가. 연결 재무정보\n1) 요약재무정보(연결)\xa0\n(단위 : 원 )\n구 분\n제65기 3분기\n제64기\n제63기\n[유동자산]\n39,833,723,898\n29,060,487,101\n23,729,452,272\nㆍ당좌자산\n32,333,330,672\n23,132,902,305\n15,627,041,696\nㆍ재고자산\n7,500,393,226\n5,927,584,796\n8,102,410,576\n[비유동자산]\n42,296,163,682\n42,458,018,123\n52,209,349,714\nㆍ투자자산\n6,990,763,055\n7,573,921,535\n4,808,645,719\nㆍ유형자산\n29,519,600,366\n29,399,326,805\n37,192,300,892\nㆍ무형자산\n467,849,578\n474,531,521\n2,208,933,367\nㆍ기타비유동자산\n5,317,950,683\n5,010,238,262\n7,999,469,736\n자산총계\n82,129,887,580\n71,518,505,224\n75,938,801,986\n[유동부채]\n22,118,808,519\n15,230,436,507\n13,533,261,102\n[비유동부채]\n7,187,178,761\n7,742,853,098\n9,847,745,051\n부채총계\n29,305,987,280\n22,973,289,605\n23,381,006,153\n[지배기업의 소유주에게 귀속되는 자본]\n52,823,900,300\n48,544,943,582\n52,557,641,482\nㆍ자본금\n59,291,502,500\n59,286,024,500\n50,899,498,000\nㆍ연결자본잉여금\n9,530,092,969\n9,514,139,231\n8,888,909,782\nㆍ연결기타자본항목\n212,954,105\n(524,477,868)\n261,152,333\nㆍ연결이익잉여금\n(16,210,649,274)\n(19,730,742,281)\n(7,491,918,633)\n[비지배지분]\n-\n272,037\n154,351\n자본총계\n52,823,900,300\n48,545,215,619\n52,557,795,833\n종속·관계·공동기업투자주식의 평가방법\n지분법\n지분법\n지분법\n2021년4월부터2021년12월까지\n2020년4월부터2021년3월까지\n2019년4월부터2020년3월까지\n매출액\n45,190,865,675\n52,020,405,167\n37,214,177,862\n영업이익(손실)\n1,288,221,908\n1,859,504,587\n(12,361,005,153)\n연결당기순이익(손실)\n3,409,465,811\n(15,633,406,102)\n(12,759,326,319)\n지배회사지분 순이익(손실)\n3,409,465,811\n(15,633,538,115)\n(11,996,066,386)\n보통주 기본주당순이익(손실)\n29\n(138)\n(116)\n보통주 희석주당순이익(손실)\n29\n(138)\n(116)\n연결에 포함된 회사수 \xa0 (단위 : 개)\n1\n2\n2\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다. \xa0\n2) 재무제표 재작성- 해당 없음 -\n3) 당기에 신규로 연결재무제표에 포함된 종속기업이나 당기 중 연결재무제표의 작성대상에서 제외된 종속기업은 다음과 같습니다. \xa0\xa0\n회계기준\n제65기 3분기\n제64기\n제63기\n한국채택국제회계기준(K-IFRS)적용 시\n1) Orient Bioresource Center Inc\n1) ORIENT SCIENCE & HEALTHCARE, INC.2) Orient Bioresource Center Inc\n1) ORIENT SCIENCE & HEALTHCARE, INC.2) Orient Bioresource Center Inc\n(주1)\n연결실체의 종속회사인 Orient Bio-Resource Center(OBRC:합병법인)와 ORIENT SCIENCE & HEALTHCARE, INC(OSH:피합병법인)는 2021년 4월 23일 합병을 실시하였으며 OSH는 소멸하였습니다.\xa0\n4) 연결재무제표 작성 기준- 자세한 사항은 \'3. 연결재무제표 주석\'을 참조 바랍니다.\xa0\n나. 별도 재무정보\n1) 요약재무정보(별도)\xa0\n(단위 : 원 )\n구 분\n제65기 3분기\n제64기\n제63기\n[유동자산]\n20,437,207,840\n22,141,651,972\n21,902,278,518\nㆍ당좌자산\n15,541,319,658\n17,031,979,705\n16,700,378,209\nㆍ재고자산\n4,173,672,479\n3,473,235,625\n3,629,453,520\nㆍ기타유동자산\n722,215,703\n1,636,436,642\n1,572,446,789\n[비유동자산]\n39,579,241,607\n40,212,480,419\xa0\n48,213,404,324\xa0\nㆍ투자자산\n14,695,105,182\n15,112,667,456\xa0\n11,909,167,950\xa0\nㆍ유형자산\n19,098,336,164\n19,615,043,180\xa0\n26,095,833,271\xa0\nㆍ무형자산\n467,849,578\n474,531,521\xa0\n2,208,933,367\xa0\nㆍ기타비유동자산\n5,317,950,683\n5,010,238,262\xa0\n7,999,469,736\xa0\n자산총계\n60,016,449,447\n62,354,132,391\n70,115,682,842\n[유동부채]\n11,300,731,902\n13,393,266,065\n11,017,173,581\n[비유동부채]\n7,187,178,761\n7,742,853,098\xa0\n9,847,745,051\xa0\n부채총계\n18,487,910,663\n21,136,119,163\n20,864,918,632\n[자본금]\n59,291,502,500\n59,286,024,500\xa0\n50,899,498,000\xa0\n[자본잉여금]\n3,869,095,656\n3,852,548,001\xa0\n3,227,318,552\xa0\n[기타자본항목]\n164,052,647\n164,052,647\xa0\n173,053,395\xa0\n[이익잉여금]\n(21,796,112,019)\n(22,084,611,920)\n(5,049,105,737)\n자본총계\n41,528,538,784\n41,218,013,228\n49,250,764,210\n종속·관계·공동기업투자주식의 평가방법\n지분법\n지분법\n지분법\n2021년4월부터2021년12월까지\n2020년4월부터2021년3월까지\n2019년4월부터2020년3월까지\n매출액\n19,697,523,694\n25,191,324,559\xa0\n23,026,306,643\xa0\n영업이익(손실)\n(2,079,623,937)\n(5,194,597,557)\n(9,712,026,775)\n당기순이익(손실)\n278,911,872\n(20,315,626,709)\n(20,626,424,531)\n보통주 기본주당순이익(손실)\n2\n(179)\n(200)\n보통주 희석주당순이익(손실)\n2\n(179)\n(200)\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.(별도 기준) 2) 재무정보 이용상의 유의점 (별도재무제표 기준)- 전기에 제출된 사업보고서의 첨부자료 ""5. 재무제표 주석""을 참조바랍니다.\xa0\n']"
